Metformin, GLP-1 receptor agonists, and chemical chaperones could have a dual effect on both the underlying insulin dysregulation and hyperinsulinemia that triggers EL, and on laminitis pathogenesis at the lamellar tissue level [41, 59]. The gene discussed is GLP1R; the disease is hyperinsulinism.